Deepnoid, Inc. operates artificial intelligence medical imaging analytics platform. Its equipment product includes DEEP:NEURO, DEEP:LUNG, DEEP:SPINE, DEEP:CHEST, DEEP:BREAST, DEEP:ENDO, DEEP:DENTAL, DEEP:FUNDUS and DEEP:PATH. It also offers AI platforms which includes DEEP: PHI, DEEP: STORE, DEEP: PACS and DEEP: PATHOLOGY. The company was founded on February 4, 2008 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company